- Home
- NMS vs FBIO Comparison
NMS vs FBIO Comparison
Compare NMS & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$1.98
Company Overview
Basic Information| Metric | NMS | FBIO |
|---|---|---|
| Founded | 1993 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.2M | 80.4M |
| IPO Year | 2014 | 2011 |
Fundamental Metrics
Financial Performance| Metric | NMS | FBIO |
|---|---|---|
| Price | $10.61 | $1.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.3K | ★ 204.8K |
| Earning Date | 01-01-0001 | 11-12-2026 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | N/A | ★ 97.40 |
| EPS | N/A | ★ 2.86 |
| Revenue | N/A | ★ $63,262,000.00 |
| Revenue This Year | N/A | $24.55 |
| Revenue Next Year | N/A | $43.73 |
| P/E Ratio | ★ N/A | $0.70 |
| Revenue Growth | N/A | ★ 9.69 |
| 52 Week Low | $9.48 | $1.79 |
| 52 Week High | $12.50 | $4.53 |
Technical Indicators
Market Signals| Indicator | NMS | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 59.50 | 48.32 |
| Support Level | $10.03 | $1.83 |
| Resistance Level | $10.75 | $2.12 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 71.77 | 68.10 |
Price Performance
Historical Comparison NMS
FBIO
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The company has Single operating segment.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.